Patents-Review.com
ClassID:

109681 ⎘

C12N2710/10333 - CPC Classification

Classification description:

dsDNA viruses; Details; Adenoviridae; Mastadenovirus, e.g. human or simian adenoviruses Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory

Recent Application in this class:
#1
20250074967
2025-03-06

IMMUNOMODULATORY FUSION PROTEINS

 #2
20240207426
2024-06-27

Covalently-modified steroid acid-peptides having enhanced stability and/or biological activity

 #3
20240180983
2024-06-06

ADENOVIRUS ENCODING IL-15

 #4
20240083953
2024-03-14

Desmoglein 2 (DSG2) Binding Proteins and Uses Therefor

 #5
20230101439
2023-03-30

Engineered Polypeptides Derived From Variable Domain of Adenovirus Penton Base

 #6
20230001014
2023-01-05

DETARGETED ADENOVIRUS VARIANTS AND RELATED METHODS

 #7
20220127308
2022-04-28

Desmoglein 2 (DSG2) binding proteins and uses therefor

 #8
20210139560
2021-05-13

Immunomodulatory fusion proteins

 #9
20210040502
2021-02-11

Simian (gorilla) adenovirus or adenoviral vectors and methods of use

 #10
20200277336
2020-09-03

Desmoglein 2 (DSG2) binding proteins and uses therefor

 #11
20190388487
2019-12-26

Detargeted adenovirus variants and related methods

 #12
20190316152
2019-10-17

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

 #13
20190269794
2019-09-05

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

 #14
20190269711
2019-09-05

Methods of treating cancer

 #15
20190092819
2019-03-28

Desmoglein 2 (DSG2) binding proteins and uses therefor

 #16
20190055579
2019-02-21

Simian (gorilla) adenovirus or adenoviral vectors and methods of use

 #17
20180221423
2018-08-09

Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration

 #18
20180134766
2018-05-17

Immunomodulatory fusion proteins

 #19
20180111993
2018-04-26

NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR

 #20
20180099015
2018-04-12

Detargeted adenovirus variants and related methods

 #21
20180066281
2018-03-08

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

 #22
20170340699
2017-11-30

Adenovirus AD36 E4ORF1 Protein For Prevention and Treatment of Non-Alcoholic Fatty Liver Disease

 #23
20170314044
2017-11-02

ADENOVIRUS CONSTRUCTS AND METHODS

 #24
20170247419
2017-08-31

Desmoglein 2 (DSG2) binding proteins and uses therefor

 #25
20170246318
2017-08-31

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

 #26
20170137781
2017-05-18

Neural cells expressing adenovirus E4ORF1, and methods of making and using the same

 #27
20160257721
2016-09-08

Desmoglein 2 (DSG2) binding proteins and uses therefor

 #28
20160243194
2016-08-25

Puma protein expression vector and use thereof in gene therapy

 #29
20160122781
2016-05-05

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

 #30
20150038412
2015-02-05

Enhanced glycemic control using Ad36E4orf1 and AKT1 inhibitor

 #31
20140314717
2014-10-23

Simian (gorilla) adenovirus or adenoviral vectors and methods of use

 #32
20140271711
2014-09-18

Adenoviral vector-based respiratory syncytial virus (RSV) vaccine

 #33
20140248308
2014-09-04

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

 #34
20140248307
2014-09-04

Affenadenovirus (gorilla) or adenoviral vectors and methods of use

 #35
20120027845
2012-02-02

Adenovirus Ad36 E4 orf1 protein for prevention and treatment of non-alcoholic fatty liver disease